Shikmim, Israel

Oren Hershkovitz

This inventor holds 1 USPTO granted patent. Top assignee: Opko Biologistics Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oren Hershkovitz. Retrieved from https://idiyas.com/inventor/oren-hershkovitz-05kkvd6o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Oren Hershkovitz: Innovator in Growth Hormone Technology

Introduction

Oren Hershkovitz is a notable inventor based in Shikmim, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of growth hormone therapies. His innovative work has led to advancements that could benefit many individuals requiring hormone treatments.

Latest Patents

Hershkovitz holds a patent for "Methods of producing long acting CTP-modified growth hormone polypeptides." This patent discloses a method for manufacturing a recombinant human growth hormone (hGH) modified by a CTP extension in a mammalian cell culture system. This innovation aims to enhance the efficacy and longevity of growth hormone treatments.

Career Highlights

Oren Hershkovitz is currently associated with Opko Biologistics Ltd., where he continues to work on groundbreaking biotechnological solutions. His expertise in recombinant protein production has positioned him as a key player in the industry.

Collaborations

Hershkovitz collaborates with various professionals in the field, including his coworker Laura Moschcovich. Their combined efforts contribute to the advancement of biopharmaceutical technologies.

Conclusion

Oren Hershkovitz's work in the field of growth hormone technology exemplifies the impact of innovation in biotechnology. His contributions are paving the way for improved treatments and therapies in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…